244 related articles for article (PubMed ID: 27702427)
1. Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin.
Martins-Marques T; Pinho MJ; Zuzarte M; Oliveira C; Pereira P; Sluijter JP; Gomes C; Girao H
J Extracell Vesicles; 2016; 5():32538. PubMed ID: 27702427
[TBL] [Abstract][Full Text] [Related]
2. Adhesion between EVs and tumor cells facilitated EV-encapsulated doxorubicin delivery via ICAM1.
Wang S; Qiao C; Kong X; Yang J; Guo F; Chen J; Wang W; Zhang B; Xiu H; He Y; Wang J; Feng H; Cai Z
Pharmacol Res; 2024 Jul; 205():107244. PubMed ID: 38821149
[TBL] [Abstract][Full Text] [Related]
3. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection.
Huang A; Liu Y; Qi X; Chen S; Huang H; Zhang J; Han Z; Han ZC; Li Z
Stem Cell Res Ther; 2022 Jun; 13(1):253. PubMed ID: 35715868
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-Loaded Extracellular Vesicles Enhance Tumor Cell Death in Retinoblastoma.
Farhat W; Yeung V; Kahale F; Parekh M; Cortinas J; Chen L; Ross AE; Ciolino JB
Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354582
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles Released by Cardiomyocytes in a Doxorubicin-Induced Cardiac Injury Mouse Model Contain Protein Biomarkers of Early Cardiac Injury.
Yarana C; Carroll D; Chen J; Chaiswing L; Zhao Y; Noel T; Alstott M; Bae Y; Dressler EV; Moscow JA; Butterfield DA; Zhu H; St Clair DK
Clin Cancer Res; 2018 Apr; 24(7):1644-1653. PubMed ID: 29070527
[No Abstract] [Full Text] [Related]
7. Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma
Patras L; Ionescu AE; Munteanu C; Hajdu R; Kosa A; Porfire A; Licarete E; Rauca VF; Sesarman A; Luput L; Bulzu P; Chiroi P; Tranca RA; Meszaros MS; Negrea G; Barbu-Tudoran L; Potara M; Szedlacsek S; Banciu M
Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 34964693
[TBL] [Abstract][Full Text] [Related]
8. Heterologous and cross-species tropism of cancer-derived extracellular vesicles.
Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P
Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511
[TBL] [Abstract][Full Text] [Related]
9. Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop.
Wu YW; Huang CC; Changou CA; Lu LS; Goubran H; Burnouf T
J Biomed Sci; 2020 Mar; 27(1):45. PubMed ID: 32200762
[TBL] [Abstract][Full Text] [Related]
10. FGF21 protects against doxorubicin-induced cardiotoxicity by inhibiting connexin 43 ubiquitination.
Huang Y; Wei C; Li P; Shao Y; Wang M; Wang F; Niu G; Sun K; Zhang Q; Gou Z; Yan X
Free Radic Biol Med; 2023 Nov; 208():748-758. PubMed ID: 37774805
[TBL] [Abstract][Full Text] [Related]
11. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
12. Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles.
Chen C; Li Y; Wang Q; Cai N; Wu L; Yan X
Anal Bioanal Chem; 2023 Mar; 415(7):1287-1298. PubMed ID: 35945289
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin Loading into Milk and Mesenchymal Stem Cells' Extracellular Vesicles as Drug Delivery Vehicles.
Mukhopadhya A; Tsiapalis D; McNamee N; Talbot B; O'Driscoll L
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986579
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalized drug localization studies in extracellular vesicles for anticancer therapy.
Pitchaimani A; Ferreira M; Palange A; Pannuzzo M; De Mei C; Spano R; Marotta R; Pelacho B; Prosper F; Decuzzi P
Nanoscale Adv; 2023 Dec; 5(24):6830-6836. PubMed ID: 38059035
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of chemotherapy-induced cardiotoxicity: toward precision prevention using extracellular vesicles.
Silver BB; Kreutz A; Weick M; Gerrish K; Tokar EJ
Front Oncol; 2024; 14():1393930. PubMed ID: 38706609
[TBL] [Abstract][Full Text] [Related]
16. Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
Takenaka T; Nakai S; Katayama M; Hirano M; Ueno N; Noguchi K; Takatani-Nakase T; Fujii I; Kobayashi SS; Nakase I
Int J Pharm; 2019 Dec; 572():118762. PubMed ID: 31610280
[TBL] [Abstract][Full Text] [Related]
17. Desialylated Mesenchymal Stem Cells-Derived Extracellular Vesicles Loaded with Doxorubicin for Targeted Inhibition of Hepatocellular Carcinoma.
Yang C; Guan Z; Pang X; Tan Z; Yang X; Li X; Guan F
Cells; 2022 Aug; 11(17):. PubMed ID: 36078050
[TBL] [Abstract][Full Text] [Related]
18. Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects.
Yao M; Ma X; Zhang X; Shi L; Liu T; Liang X; Zhao H; Li X; Li L; Gao H; Jia B; Wang F
Theranostics; 2019; 9(3):747-760. PubMed ID: 30809306
[TBL] [Abstract][Full Text] [Related]
19. Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity.
Tian C; Yang Y; Bai B; Wang S; Liu M; Sun RC; Yu T; Chu XM
Int J Biol Sci; 2021; 17(5):1328-1338. PubMed ID: 33867849
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy.
Chitti SV; Nedeva C; Manickam R; Fonseka P; Mathivanan S
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
